Overview
Pharmaceutical regulation consulting addresses FDA approval processes, drug labeling requirements, post-market surveillance obligations, and compliance with federal and state pharmaceutical law. MDT Expert Consulting connects legal teams with former FDA officials, regulatory affairs executives, and academic pharmacologists who evaluate whether pharmaceutical companies, distributors, and dispensers met applicable regulatory standards in drug approval, off-label promotion, recall obligations, and regulatory compliance.
Pre-Litigation Support
Pre-litigation pharmaceutical regulation review helps counsel assess whether a drug manufacturer, distributor, or pharmacy complied with FDA requirements and industry standards. Experts evaluate regulatory submissions, labeling history, adverse event reporting records, and promotional materials to determine whether the conduct at issue constituted a regulatory violation. This analysis shapes early case strategy in mass tort, product liability, and government enforcement matters.
Litigation Support
During litigation, pharmaceutical regulation experts assist in interpreting complex regulatory records, identifying failures in post-market safety monitoring, and evaluating the adequacy of drug warnings and labeling. They help counsel frame discovery around FDA correspondence, internal regulatory files, and clinical data, and they evaluate whether changes in labeling or formulary were handled in accordance with applicable requirements.
Arbitration Support
In arbitration, pharmaceutical regulation experts address disputes involving supply chain contracts, formulary agreements, licensing arrangements, and regulatory compliance obligations. Their command of the regulatory landscape allows them to efficiently address the intersection of federal requirements and commercial disputes in alternative dispute resolution settings.